21-44509275-CAT-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_144991.3(TSPEAR):βc.1676_1677delβ(p.Tyr559CysfsTer134) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000483 in 1,613,966 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.000039 ( 0 hom., cov: 32)
Exomes π: 0.000049 ( 0 hom. )
Consequence
TSPEAR
NM_144991.3 frameshift
NM_144991.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.24
Genes affected
TSPEAR (HGNC:1268): (thrombospondin type laminin G domain and EAR repeats) This gene encodes a protein that contains a N-terminal thrombospondin-type laminin G domain and several tandem arranged epilepsy-associated repeats (EARs). A mutation in this gene is the cause of autosomal recessive deafness-98. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 21-44509275-CAT-C is Pathogenic according to our data. Variant chr21-44509275-CAT-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 817061.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-44509275-CAT-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPEAR | NM_144991.3 | c.1676_1677del | p.Tyr559CysfsTer134 | frameshift_variant | 10/12 | ENST00000323084.9 | NP_659428.2 | |
TSPEAR-AS1 | NR_103707.1 | n.1240_1241del | non_coding_transcript_exon_variant | 5/7 | ||||
TSPEAR | NM_001272037.2 | c.1472_1473del | p.Tyr491CysfsTer134 | frameshift_variant | 11/13 | NP_001258966.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPEAR | ENST00000323084.9 | c.1676_1677del | p.Tyr559CysfsTer134 | frameshift_variant | 10/12 | 1 | NM_144991.3 | ENSP00000321987 | P1 | |
TSPEAR | ENST00000397916.1 | n.1631_1632del | non_coding_transcript_exon_variant | 10/11 | 1 | |||||
TSPEAR-AS1 | ENST00000451035.2 | n.795_796del | non_coding_transcript_exon_variant | 4/6 | 5 | |||||
TSPEAR | ENST00000642437.1 | c.*1621_*1622del | 3_prime_UTR_variant, NMD_transcript_variant | 11/13 | ENSP00000496535 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152110Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
152110
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251348Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135880
GnomAD3 exomes
AF:
AC:
11
AN:
251348
Hom.:
AF XY:
AC XY:
6
AN XY:
135880
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000493 AC: 72AN: 1461856Hom.: 0 AF XY: 0.0000413 AC XY: 30AN XY: 727232
GnomAD4 exome
AF:
AC:
72
AN:
1461856
Hom.:
AF XY:
AC XY:
30
AN XY:
727232
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152110Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74302
GnomAD4 genome
AF:
AC:
6
AN:
152110
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74302
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 10, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the TSPEAR protein in which other variant(s) (p.Val576Leufs*38) have been determined to be pathogenic (PMID: 27736875, 30046887). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 817061). This variant is also known as c.1472_1473delAT. This frameshift has been observed in individual(s) with deafness (PMID: 34042254). This variant is present in population databases (rs781890406, gnomAD 0.01%). This sequence change results in a frameshift in the TSPEAR gene (p.Tyr559Cysfs*134). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 111 amino acid(s) of the TSPEAR protein and extend the protein by 22 additional amino acid residues. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 05, 2024 | Frameshift variant predicted to result in abnormal protein length as the last 111 amino acid(s) are replaced with 133 different amino acid(s), and other similar variants have been reported in HGMD; This variant is associated with the following publications: (PMID: 34042254, 26969326) - |
TSPEAR-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 10, 2024 | The TSPEAR c.1676_1677delAT variant is predicted to result in a frameshift and premature protein termination (p.Tyr559Cysfs*134). This variant was reported, along with another variant in TSPEAR in an individual with Hearing loss (reported as c.1472_1473delAT in Sloan-Heggen et al. 2016. PubMed ID: 26969326). This variant is reported in 0.0093% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in TSPEAR are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at